Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
4
67%
Ph phase_4
1
17%
Ph early_phase_1
1
17%

Phase Distribution

1

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
4(66.7%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(4)

Detailed Status

Completed4
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 24 (66.7%)
Phase 41 (16.7%)

Trials by Status

recruiting233%
completed467%

Recent Activity

2 active trials
Showing 5 of 6
recruitingearly_phase_1

Efficacy of Dihydroartemisinin for Treating Acne Vulgaris

NCT07007078
completedphase_2

Efficacy of Dihydroartemisinin for Treating PCOS

NCT06417099
recruitingphase_2

Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

NCT06842524
completedphase_4

The Effect of Dihydroartemisinin in PCOS

NCT05465135
completedphase_2

Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua

NCT06036030
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07007078Early Phase 1

Efficacy of Dihydroartemisinin for Treating Acne Vulgaris

Recruiting
NCT06417099Phase 2

Efficacy of Dihydroartemisinin for Treating PCOS

Completed
NCT06842524Phase 2

Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

Recruiting
NCT05465135Phase 4

The Effect of Dihydroartemisinin in PCOS

Completed
NCT06036030Phase 2

Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua

Completed
NCT05829187Phase 2

Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6